RSS-Feed abonnieren
DOI: 10.1055/s-0041-1730994
Scenario of Elective Colorectal Oncology Surgeries During the COVID-19 Pandemic
Cenário das cirurgias colorretais oncológicas eletivas em meio à pandemia de COVID-19Abstract
The COVID-19 pandemic has changed the world health scenario, causing numerous problems related to the overload of services. In this scenario, the approach to oncological diseases becomes a challenge, considering the risk of progression of cancer disease and death due to delay in diagnosis and treatment. Faced with this exceptional situation, coloproctology services have been forced to change their routine to adapt to the new reality, considering risks and benefits in the conduct of these patients. Thus, the experience of the coloproctology service at the Santa Casa de São Paulo, São Paulo, state of São Paulo, Brazil, during the beginning of the COVID-19 pandemic is described, evaluating the possibility of maintaining elective oncological surgeries through selection by directed anamnesis.
Method Retrospective cohort study with prospective collection comparing colorectal surgery for cancer before and during the pandemic from December 2019 to July 2020.
Results In total, 81 patients were included. During the pandemic, 41 patients were operated on with 2 perioperative contaminations by COVID-19. Both length of stay and complications were not different between groups.
Conclusion Since there was no increase in COVID-19 morbidity and mortality in elective oncology surgeries with patients screened for guided anamnesis, it is worth considering this method for maintaining surgical procedures even in the event of a pandemic.
Resumo
A pandemia do COVID-19 modificou o cenário mundial da saúde, ocasionando inúmeros problemas relacionados à sobrecarga dos serviços. Neste contexto, a abordagem das doenças oncológicas se tornou um desafio, tendo em vista que o atraso no diagnóstico e no tratamento oncológico resulta em maior risco de progressão de doença e óbito. Frente a esta situação excepcional, os serviços de coloproctologia foram obrigados a mudar a rotina, considerando riscos e benefícios na condução dos pacientes. Assim, descreve-se a experiência do serviço de coloproctologia da Santa Casa de São Paulo, São Paulo, SP, Brasil, durante o início da pandemia de COVID-19, avaliando a possibilidade de manutenção das cirurgias eletivas oncológicas através da seleção por anamnese dirigida.
Método Coorte retrospectiva com coleta prospectiva comparando cirurgias colorretais oncológicas realizadas de dezembro de 2019 a julho de 20202, comparando casos operados antes e durante a pandemia.
Resultados No total, 81 pacientes foram incluídos. Durante a pandemia, 41 pacientes foram operados, com duas contaminações perioperatórias por COVID-19. Nem o tempo de internação nem as complicações foram diferentes entre os grupos.
Conclusão Uma vez que não houve aumento da morbimortalidade por COVID-19 nas cirurgias oncológicas eletivas com pacientes triados por anamnese dirigida, vale considerar este método para a manutenção dos procedimentos cirúrgicos mesmo em vigência da pandemia.
Keywords
colorectal surgery - coronavirus infections - colon neoplasms - rectal neoplasms - colorectal neoplasms - COVID-19Palavras-chave
cirurgia colorretal - infecções por coronavírus - neoplasias do cólon - neoplasias retais - neoplasias colorretais - COVID-19Publikationsverlauf
Eingereicht: 17. September 2020
Angenommen: 18. Januar 2021
Artikel online veröffentlicht:
30. Juni 2021
© 2021. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
- 2 Vecchione L, Stintzing S, Pentheroudakis G, Douillard JY, Lordick F. ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer. ESMO Open 2020; 5 (Suppl. 03) e000826 DOI: 10.1136/esmoopen-2020-000826.
- 3 England N. COVID-19 rapid guideline: delivery of systemic anticancer treatments: NICE: National Institute for Health and Care Excellence. 2020 : Available from: https://www.nice.org.uk/guidance/ng161/resources/COVID-19-rapidguideline-delivery-of-systemic-anticancertreatments-pdf-66141895710661
- 4 Amorim GLS, Assad DX, Ferrari BL, Rosa DD, Pereira BP, Clara RO. et al Breast oncology and the COVID-19 pandemic: Recommendations from the Brazilian Society of Clinical Oncology (SBOC). Braz J Oncol. 2020; 16: e-20190024
- 5 American College of Surgeons. COVID-19: Guidance for Triage of Non-Emergent Surgical Procedures. 2020 : Available from: https://www.facs.org/covid-19/clinical-guidance/triage
- 6 Forrester JD, Nassar AK, Maggio PM, Hawn MT. Precautions for operating room team members during COVID-19 pandemic. J Am Coll Surg 2020; 230 (06) 1098-1101
- 7 Correia MITD, Ramos RF, Bahten LCV. The surgeons and the COVID-19 pandemic. Rev Col Bras Cir 2020; 47: e20202536
- 8 Heniford BT, Shao J, Deerenberg E, Brown J. and the MIS Task Force. Statement for Laparoscopic Surgery During the COVID-19 Pandemic
- 9 Lei S, Jiang F, Su W. et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine 2020; 21: 100331 DOI: 10.1016/j.eclinm.2020.100331.
- 10 Paul S Myles et al, Mitigating the risks of surgery during the COVID-19 pandemic
- 11 Wenhua Liang, Weijie Guan, Ruchong Chen, Wei Wang, Jianfu Li, Ke Xu, Caichen Li, Qing Ai, Weixiang Lu, Hengrui Liang, Shiyue Li, Jianxing He
- 12 Liang W, Guan W, Chen R. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21 (03) 335-337 DOI: 10.1016/S1470-2045(20)30096-6.
- 13 Alimoglu O, Erol CI, Kilic F, Baysal H. Cancer surgery during the Covid-19 pandemic in Turkey. Int J Surg 2020; 79: 54-55 DOI: 10.1016/j.ijsu.2020.05.040.
- 14 Dinesh C. Sharma, Lockdown poses new challenges for cancer care in India Lancet Oncol 2020 Published Online May 29, 2020 https://doi.org/10.1016/S1470–2045(20)30312–0
- 15 International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. ‘‘Radiotherapy & Oncology during the COVID-19 pandemic”, Vol. 146, 2020
- 16 Dinmohamed AG, Visser O, Verhoeven RHA. et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol 2020; 21 (06) 750-751
- 17 Marshall JL, Yarden RI, Weinberg BA. Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit. Colorectal Cancer 2020;0(0). Doi: 10.2217/crc-2020-0010
- 18 http://www.saude.sp.gov.br/resources/cve-centro-de-vigilancia-epidemiologica/areas-de-vigilancia/doencas-de-transmissao-respiratoria/coronavirus/coronavirus010720_situacao_epidemiologica.pdf
- 19 Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study May 29, 2020 https://doi.org/10.1016/S0140-6736(20)31182-X
- 20 Silva, Leonardo Emilio et al. Elective surgeries in the “new normal” post-COVID-19 pandemic: to test or do not test?. Revista do Colégio Brasileiro de Cirurgiões [online]. 2020, v. 47 [Acessado 27 Maio 2021], e20202649. Disponível em: https://doi.org/10.1590/0100-6991e-20202649. Epub 12 Jun 2020
- 21 Shrikhande SV, Pai PS, Bhandare MS. et al; all collaborators from Department of Surgical Oncology. Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care Policy. Ann Surg 2020; 272 (03) e249-e252 DOI: 10.1097/SLA.0000000000004116.